Skip to main content
. 2018 Mar 1;3(1):74–84. doi: 10.1089/can.2017.0046

FIG. 2.

FIG. 2.

Knowledge and perspectives of MMJ and the NY-MMP. Participants (n=164 answered) rated (A) their knowledge of the eCB system, the extent to which they agree with the statement that MMJ should be an option available to patients, (B) their familiarity with the patient (n=163 answered) and physician requirements for participating in the MMP, and (C) their opinions regarding the number of qualifying conditions and available MMJ formulations. eCB, endocannabinoid; NY-MMP, New York State Medical Marijuana Program.